P435: Effectiveness of therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease patients. Systematic review and meta-analysisECCO '18 Vienna
2018
P436: Ileal pouch-anal anastomosis with fluorescence angiography: Initial experience and potential applicationECCO '18 Vienna
2018
P437: Higher adalimumab maintenance regimens are more effective than standard maintenance doses in Crohn’s disease patients who have failed infliximabECCO '18 Vienna
2018
P438: Reinduction with ustekinumab in Crohn’s disease patients with a loss of response to treatmentECCO '18 Vienna
2018
P439: Monitoring inflammatory Bowel disease activity in a virtual biologic clinic: The effects of proactive therapeutic drug monitoring on patient reported outcome measuresECCO '18 Vienna
2018
P440: Early changes in the pharmacokinetic profile of vedolizumab-treated patients with inflammatory bowel disease may predict response after dose optimisationECCO '18 Vienna
2018
P441: Higher education, professional occupation and upper socio-economic status is associated with lower adherence to medications in patients with inflammatory bowel diseaseECCO '18 Vienna
2018
P442: The additional value of cytapheresis therapy in patients with severe ulcerative colitis treated with oral tacrolimusECCO '18 Vienna
2018
P443: Systematic analysis of annual health resource utilisation and costs in hospitalised inflammatory bowel disease patients in SwitzerlandECCO '18 Vienna
2018
P445: Patients with active perianal fistulas have a reduced physical health compared with Crohn’s patients without perianal fistulasECCO '18 Vienna
2018
P446: Patient and public involvement in a clinical trial for perianal Crohn’s fistulaECCO '18 Vienna
2018
P447: Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximabECCO '18 Vienna
2018
P448: Remission induction therapy with tacrolimus and biological combination therapy for severe ulcerative colitisECCO '18 Vienna
2018
P449: Double assessment of ileal pouch-anal anastomosis before ileostomy reversalECCO '18 Vienna
2018
P451: Long-term surgical outcome of ileal pouch-anal anastomosis when used for well-defined Crohn’s diseaseECCO '18 Vienna
2018
P452: Medium to long-term outcomes in patients receiving accelerated dose infliximab induction for acute severe ulcerative colitis (ASUC) in a multi-centre cohortECCO '18 Vienna
2018
P453: Pre-operative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease: A systematic review and meta-analysisECCO '18 Vienna
2018